The rising trend of continuous flow is bringing economic and safety benefits to manufacturers, says Dr Shawn Conway, engineering R&D director for Cambrex.
European Pharmaceutical Manufacturer catches up with Norgine CEO Peter Stein to discuss pharma trends, US and EU drug approvals and the company’s approach to improvement.
At the confluence of Moore’s law and Metcalfe’s law the next frontier in drug delivery becomes data-driven, personalised and outcome-based- Dr Ramin Rafiei, director of digital healthcare at SHL Group writes.
David J. Balderson, vice president, Global Safety Operations at Sciformix - a Covance company - examines how automation is helping to reduce negative drug outcomes.
With the high costs of drug discovery, Tyler Golato, scientific lead at Molecule, discusses why new business models are needed if innovation is to continue.
Shabbir Mostafa, global key account director for Recipharm Inhalation Solutions, looks at the techniques to reduce time to market during inhalation drug development and manufacturing.
Ken Moir, VP marketing director at NiceLabel explains why labelling is an unassuming challenge for pharma manufacturers wanting to keep up with regulatory compliance.
Organisation psychologist Jane Piper has worked with pharma companies around the world to help them increase productivity and increase employee wellbeing. Here she outlines the steps needed to increase productivity.
Here, Karen Rossington and Siobhan Murphy from Contec guide readers through the implications of the EU Biocidal Products Regulation (BPR) on life science cleanroom users.
Robert Gaertner, director of strategy for quality at Veeva, explains how digital transformation is improving pharmaceutical processes across the industry.
